Skip to main content

Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay

Nov 09, 2021 4:20 pm

Dr. Kay discusses abstract 1940 and abstract 980 presented at the ACR21 annual meeting.

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×